Advancements toward an improved
vaccine against Bacillus anthracis, the causative agent of
anthrax, have focused on formulations composed of the protective
antigen (PA) adsorbed to
aluminum hydroxide. However, due to the labile nature of PA,
antigen stability is a primary concern for
vaccine development. Thus, there is a need for a delivery system capable of preserving the immunogenicity of PA through all the steps of
vaccine fabrication, storage, and administration. In this work, we demonstrate that biodegradable amphiphilic polyanhydride nanoparticles, which have previously been shown to provide controlled
antigen delivery,
antigen stability, immune modulation, and protection in a single dose against a pathogenic challenge, can stabilize and release functional PA. These nanoparticles demonstrated
polymer hydrophobicity-dependent preservation of the
biological function of PA upon encapsulation, storage (over extended times and elevated temperatures), and release. Specifically, fabrication of amphiphilic polyanhydride nanoparticles composed of 1,6-bis(p-carboxyphenoxy)hexane and 1,8-bis(p-carboxyphenoxy)-3,6-dioxaoctane best preserved PA functionality. These studies demonstrate the versatility and superiority of amphiphilic nanoparticles as
vaccine delivery vehicles suitable for long-term storage.